Stock listing
BX Swiss:JNJ Johnson & Johnson Aktie
Swiss listing (BX Swiss) of Johnson & Johnson · home listing NYSE:JNJ
Follow Johnson & Johnson into a list and get an email when it puts out news.
Home listing price · NYSE:JNJ
$273.20 USD -2.00 (-0.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:JNJ
- Day range
- $273.13 – $282.02 USDOct 30, 2026
- Volume
- 8.95M sharesOct 30, 2026
- Market cap
- $658.4B USDAt the close on Oct 30, 2026 · price × 2.41B shares outstanding
- 52-week range
- $185.12 – $282.02 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.82B USDMedian day 6.33M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:JNJ · Home | $273.20 USD | -2.00 (-0.7%) | 8,948,945 | $280.00 | $282.02 | $273.13 | $275.20 | Close on Oct 30, 2026 |
| BCBA:JNJ | $30,280 ARS | -40 (-0.1%) | 11,309 | $30,660 | $31,080 | $30,160 | $30,320 | Close on Oct 30, 2026 |
| Xetra:JNJ | €239.95 EUR | +4.90 (+2.1%) | 1,123 | €238.40 | €241.20 | €237.35 | €235.05 | Close on Oct 27, 2026 |
| B3:JNJB34 | 96.00 BRL | +6.51 (+7.3%) | 10,535 | 95.95 | 96.00 | 93.97 | 89.49 | Close on Oct 27, 2026 |
| BMV:JNJ | $5,008.00 MXN | +79.71 (+1.6%) | 464 | $4,964.40 | $5,008.00 | $4,964.40 | $4,928.29 | Close on Oct 27, 2026 |
| Cboe Canada:JNJ | $34.16 CAD | +0.66 (+2.0%) | 6,825 | $33.85 | $34.21 | $33.85 | $33.50 | Close on Oct 27, 2026 |
| Frankfurt:JNJ | €244.60 EUR | +1.85 (+0.8%) | 382 | €248.65 | €251.45 | €244.60 | €242.75 | Close on Oct 30, 2026 |
| Munich:JNJ | €240.95 EUR | +4.05 (+1.7%) | 8 | €238.70 | €240.95 | €238.70 | €236.90 | Close on Oct 27, 2026 |
| Hamburg:JNJ | €247.05 EUR | +6.90 (+2.9%) | — | €248.60 | €248.60 | €247.05 | €240.15 | Close on Oct 30, 2026 |
| Dusseldorf:JNJ | €246.55 EUR | +5.55 (+2.3%) | — | €248.25 | €250.25 | €246.55 | €241.00 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:JNJ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $273.20 | -2.00 | -0.7% | $280.00 | $282.02 | $273.13 | 8,948,945 | |
| $275.20 | +4.16 | +1.5% | $275.31 | $278.05 | $273.60 | 5,989,828 | |
| $271.04 | +2.31 | +0.9% | $265.83 | $272.75 | $264.20 | 6,396,275 | |
| $268.73 | +2.43 | +0.9% | $265.25 | $269.09 | $264.83 | 5,774,670 | |
| $266.30 | +2.49 | +0.9% | $266.74 | $272.36 | $264.97 | 5,734,551 | |
| $263.81 | -3.80 | -1.4% | $265.82 | $266.03 | $262.40 | 5,305,727 | |
| $267.61 | +9.83 | +3.8% | $260.54 | $269.67 | $259.04 | 9,711,497 | |
| $257.78 | -1.58 | -0.6% | $257.50 | $257.80 | $254.56 | 6,148,851 | |
| $259.36 | +5.57 | +2.2% | $257.48 | $260.77 | $256.42 | 7,634,901 | |
| $253.79 | -1.77 | -0.7% | $254.43 | $255.56 | $251.52 | 8,678,979 | |
| $255.56 | +2.28 | +0.9% | $255.52 | $257.55 | $254.00 | 6,548,000 | |
| $253.28 | -0.63 | -0.2% | $257.11 | $262.45 | $252.62 | 9,274,700 | |
| $253.91 | +5.30 | +2.1% | $249.10 | $253.94 | $248.50 | 9,662,000 | |
| $248.61 | -15.12 | -5.7% | $254.56 | $256.18 | $245.17 | 16,647,100 | |
| $263.73 | +2.29 | +0.9% | $261.60 | $264.39 | $260.37 | 5,902,500 | |
| $261.44 | +4.96 | +1.9% | $255.09 | $261.61 | $254.99 | 5,726,000 | |
| $256.48 | -1.97 | -0.8% | $256.22 | $257.80 | $251.95 | 6,172,800 | |
| $258.45 | +3.67 | +1.4% | $256.21 | $260.68 | $255.73 | 5,402,200 | |
| $254.78 | +1.85 | +0.7% | $254.15 | $255.48 | $251.17 | 5,661,000 | |
| $252.93 | -3.10 | -1.2% | $256.00 | $256.24 | $252.51 | 10,026,800 | |
| $256.03 | -2.63 | -1.0% | $259.38 | $259.38 | $255.12 | 10,940,400 | |
| $258.66 | -6.08 | -2.3% | $263.68 | $263.98 | $258.33 | 8,289,000 | |
| $264.74 | -2.83 | -1.1% | $267.91 | $268.48 | $264.51 | 6,341,000 | |
| $267.57 | -4.38 | -1.6% | $269.11 | $271.89 | $265.59 | 5,620,500 | |
| $271.95 | +0.73 | +0.3% | $270.17 | $273.78 | $269.27 | 7,185,600 | |
| $271.22 | +0.54 | +0.2% | $271.70 | $272.25 | $269.26 | 4,085,700 | |
| $270.68 | +1.51 | +0.6% | $269.52 | $275.23 | $269.01 | 6,320,600 | |
| $269.17 | -0.02 | 0.0% | $269.47 | $272.14 | $266.50 | 6,632,700 | |
| $269.19 | -0.28 | -0.1% | $267.51 | $270.10 | $265.04 | 5,680,700 | |
| $269.47 | -0.52 | -0.2% | $271.74 | $273.73 | $268.50 | 4,485,300 | |
| $269.99 | -0.23 | -0.1% | $269.45 | $272.11 | $267.20 | 16,428,400 | |
| $270.22 | +2.94 | +1.1% | $268.00 | $270.87 | $267.11 | 6,568,800 | |
| $267.28 | +0.08 | 0.0% | $266.81 | $268.65 | $266.30 | 4,887,300 | |
| $267.20 | +0.88 | +0.3% | $265.81 | $267.20 | $260.68 | 5,283,500 | |
| $266.32 | +0.74 | +0.3% | $271.00 | $271.55 | $266.19 | 4,740,800 | |
| $265.58 | -0.77 | -0.3% | $268.03 | $270.40 | $265.25 | 4,701,200 | |
| $266.35 | -0.73 | -0.3% | $270.21 | $271.27 | $265.72 | 4,929,500 | |
| $267.08 | -2.04 | -0.8% | $268.51 | $270.10 | $266.73 | 6,124,600 | |
| $269.12 | -6.11 | -2.2% | $271.28 | $271.99 | $266.88 | 8,084,700 | |
| $275.23 | -3.20 | -1.1% | $275.13 | $277.80 | $274.75 | 4,320,100 | |
| $278.43 | +3.22 | +1.2% | $277.32 | $278.89 | $273.16 | 5,940,300 | |
| $275.21 | +4.02 | +1.5% | $274.74 | $281.07 | $273.53 | 7,910,600 | |
| $271.19 | +5.34 | +2.0% | $270.83 | $271.91 | $267.02 | 6,033,600 | |
| $265.85 | -2.19 | -0.8% | $267.13 | $267.77 | $265.17 | 7,900,100 | |
| $268.04 | +2.27 | +0.9% | $265.78 | $268.38 | $264.27 | 5,765,600 | |
| $265.77 | -4.23 | -1.6% | $268.45 | $268.45 | $263.83 | 7,306,200 | |
| $270.00 | -3.14 | -1.1% | $271.97 | $272.91 | $269.55 | 7,214,100 | |
| $273.14 | +0.10 | 0.0% | $271.00 | $273.80 | $270.18 | 4,687,000 | |
| $273.04 | +2.80 | +1.0% | $269.74 | $273.98 | $268.57 | 5,436,100 | |
| $270.24 | +2.87 | +1.1% | $267.83 | $272.66 | $267.00 | 6,186,800 | |
| $267.37 | -6.04 | -2.2% | $273.40 | $273.40 | $267.37 | 6,475,900 | |
| $273.41 | +2.30 | +0.8% | $273.00 | $276.47 | $270.56 | 7,728,500 | |
| $271.11 | +8.74 | +3.3% | $267.67 | $271.73 | $266.33 | 7,838,200 | |
| $262.37 | +2.02 | +0.8% | $258.87 | $264.28 | $258.01 | 5,515,500 | |
| $260.35 | -1.73 | -0.7% | $260.65 | $261.71 | $259.16 | 4,998,100 | |
| $262.08 | +1.22 | +0.5% | $261.73 | $262.62 | $259.65 | 4,852,700 | |
| $260.86 | +1.06 | +0.4% | $256.00 | $261.41 | $255.26 | 4,629,300 | |
| $259.80 | -2.01 | -0.8% | $261.23 | $264.15 | $258.36 | 5,945,900 | |
| $261.81 | +2.57 | +1.0% | $259.06 | $262.00 | $258.55 | 8,985,100 | |
| $259.24 | +2.26 | +0.9% | $255.89 | $259.60 | $255.12 | 6,532,100 | |
| $256.98 | -0.61 | -0.2% | $261.71 | $262.11 | $255.28 | 6,931,800 | |
| $257.59 | +2.66 | +1.0% | $255.25 | $259.32 | $254.47 | 6,472,600 | |
| $254.93 | +0.52 | +0.2% | $254.41 | $255.52 | $250.44 | 7,362,400 | |
| $254.41 | -1.94 | -0.8% | $254.97 | $257.75 | $250.91 | 8,136,300 | |
| $256.35 | +0.53 | +0.2% | $256.01 | $258.48 | $253.29 | 6,782,100 | |
| $255.82 | -9.71 | -3.7% | $259.03 | $260.52 | $254.56 | 8,216,500 |
- Ticker
- BX Swiss:JNJ
- Asset type
- Stock
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Oct 29, 2026
Johnson & Johnson: Record 26 Abstracts at TCT 2026 Adds to More than 20 Years of Data Demonstrating the Safety, Efficacy and Cost Effectiveness of Impella Heart Pumps
Latest earnings call · Oct 13, 2026
Johnson & Johnson (NYSE:JNJ) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 13, 2026
Q3 2026 Earnings Presentation
Earnings · 27 slides
Calls
Replays
Johnson & Johnson (NYSE:JNJ) Q3 2026 Earnings Call
Tue, Oct 13, 2026 · 8:30 AM ET
Watch TranscriptJohnson & Johnson (NYSE:JNJ) Q2 2026 Earnings Call
Wed, Jul 15, 2026 · 8:30 AM ET
Watch TranscriptJohnson & Johnson (NYSE:JNJ) Q1 2026 Earnings Call
Tue, Apr 14, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Johnson & Johnson: Record 26 Abstracts at TCT 2026 Adds to More than 20 Years of Data Demonstrating the Safety, Efficacy and Cost Effectiveness of Impella Heart Pumps
Oct 29, 2026
Closed $275.20 (+1.5%) on Oct 29, 2026
Johnson & Johnson to Host Enterprise Business Review
Oct 27, 2026
Closed $268.73 (+0.9%) on Oct 27, 2026
Subcutaneous RYBREVANT®▼ (amivantamab) demonstrates 77% overall response rate in first-line treatment of patients with certain types of advanced head and neck cancer
Oct 25, 2026
Closed $266.30 (+0.9%) on Oct 26, 2026
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
Oct 25, 2026
Closed $266.30 (+0.9%) on Oct 26, 2026
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
Oct 25, 2026
Closed $266.30 (+0.9%) on Oct 26, 2026
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk localised or locally advanced prostate cancer
Oct 24, 2026
Closed $266.30 (+0.9%) on Oct 26, 2026
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
Oct 24, 2026
Closed $266.30 (+0.9%) on Oct 26, 2026
Johnson & Johnson advances the next generation of solid tumor therapies with new data at ESMO 2026
Oct 23, 2026
Closed $263.81 (-1.4%) on Oct 23, 2026
European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapse
Oct 23, 2026
Closed $263.81 (-1.4%) on Oct 23, 2026
Quarterly Report for Quarter Ending September 27, 2026 (Form 10-Q)
Oct 21, 2026
Closed $267.61 (+3.8%) on Oct 22, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 27 slides · Oct 13, 2026
Q2 2026 Earnings Presentation
Earnings · 24 slides · Jul 15, 2026
Q1 2026 Earnings Presentation
Earnings · 28 slides · Apr 14, 2026
Q4 2025 Earnings Presentation
Earnings · 33 slides · Jan 21, 2026
Johnson & Johnson on 6ix
- News releases
- 183 in the last 12 months · 199 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Oct 13, 2026
- Decks
- 69 decks · latest Oct 13, 2026
Where Johnson & Johnson is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:JNJ · Home listing | NYSE | United States | USD |
| gettex:JNJ | gettex | Germany | EUR |
| BCBA:JNJ | BCBA | Argentina | ARS |
| Xetra:JNJ | Xetra | Germany | EUR |
| B3:JNJB34 | B3 | Brazil | BRL |
| Tradegate:JNJ | Tradegate | Germany | EUR |
| SET:JNJ03 | SET | Thailand | THB |
| BCBA:JNJD | BCBA | Argentina | USD |
| TSX:JNJ | TSX | Canada | CAD |
| LS Exchange:853260 | LS Exchange | Germany | EUR |
| BMV:JNJ | BMV | Mexico | MXN |
| Cboe Canada:JNJ | Cboe Canada | Canada | CAD |
| BVC:JNJ | BVC | Colombia | COP |
| Milan:1JNJ | Milan | Italy | EUR |
| Lang & Schwarz:853260 | Lang & Schwarz | Germany | EUR |
| Frankfurt:JNJ | Frankfurt | Germany | EUR |
| Munich:JNJ | Munich | Germany | EUR |
| Turquoise:JNJN | Turquoise | United Kingdom | USD |
| Stuttgart:JNJ | Stuttgart | Germany | EUR |
| LSE:0R34 | LSE | United Kingdom | USD |
| EUROTLX:4JNJ | EUROTLX | Italy | EUR |
| VIE:JNJ | Vienna | Austria | EUR |
| BOATS:JNJ | BOATS | United States | USD |
| BCBA:JNJC | BCBA | Argentina | USD |
| BCS:JNJCL | BCS | Chile | CLP |
| SIX Swiss:JNJ.USD | SIX Swiss | Switzerland | USD |
| Hamburg:JNJ | Hamburg | Germany | EUR |
| Hanover:JNJ | Hanover | Germany | EUR |
| BIVA:JNJ | BIVA | Mexico | MXN |
| BCS:JNJ | BCS | Chile | USD |
| Dusseldorf:JNJ | Dusseldorf | Germany | EUR |
| BX Swiss:JNJ · This page | BX Swiss | Switzerland | CHF |
| BSESOF:JNJ | BSESOF | Bulgaria | EUR |
| SIX Swiss:JNJ | SIX Swiss | Switzerland | CHF |
| BCBA:JNJ.B | BCBA | Argentina | ARS |
| Aquis:JNJD | Aquis | United Kingdom | EUR |
| BVL:JNJUS | BVL | Peru | PEN |
| gettex:JNJ0 | gettex | Germany | EUR |
| BX Swiss:JNJUSD | BX Swiss | Switzerland | USD |
| Aquis:JNJD | Aquis | United Kingdom | EUR |
| Dusseldorf:JNJ0 | Dusseldorf | Germany | EUR |
| Frankfurt:JNJ0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A3ET7S | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3ET7S | LS Exchange | Germany | EUR |
| Munich:JNJ0 | Munich | Germany | EUR |
| BCBA:JNJ.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Johnson & Johnson.